Equation of state of strongly coupled Hamiltonian lattice QCD at finite density

We calculate the equation of state of strongly coupled Hamiltonian lattice QCD at finite density by constructing a solution to the equation of motion corresponding to an effective Hamiltonian using Wilson fermions. We find that up to and beyond the chiral symmetry restoration density the pressure of the quark Fermi sea can be negative indicating its mechanical instability. This result is in qualitative agreement with continuum models and should be verifiable by future numerical simulations.Comment: 14 pages, 2 EPS figures. Revised version - added discussion on the equation of stat

Lessons From the Current Japanese Triple Helix Model

Since mid-1990s, the Japanese government has encouraged university-industry collaboration to foster innovations for economic growth. Learning from the American licensing model of technology transfer, Japanese Bay-Dole Act and TLO (Technology Licensing Organization) Act were enacted in late 1990s. In addition, the corporatization of Japanese National Universities (JNUs) in 2004 spurred their technology-transfer activities to obtain external funds. As a result, more than 50 TLOs has been established since FY1998, and also the number of patent application and licensed patents were increased at JUNs rapidly after FY2004. However, the licensing income has been stayed poor and some of TLOs were abolished. There are few evidences that the introduction of licensing model of technology transfer into Japan could contribute to innovation properly. Therefore, this study will try to clarify if licensing model of technology transfer work in Japan by analyzing the Japanese National University (JNU) patent. There are 20,485 applied patent, which invented by JNU's researcher(s) from FY2004 to 2007. 38% of them were applied by solely by JNUs and 52% were by JNU and Private Firms etc. In the Japanese Patent Act, jointly applied patents are not licensed to the third party without the consent of co-applicant(s). Hence, more than half of the patent invented by JNU researchers is not basically used for patent licensing. Consequently, JNUs and TLOs face difficulties in patent licensing under the current Patent Act

Adenoviral targeting of malignant melanoma for fluorescence-guided surgery prevents recurrence in orthotopic nude-mouse models.

Malignant melanoma requires precise resection in order to avoid metastatic recurrence. We report here that the telomerase-dependent, green fluorescent protein (GFP)-containing adenovirus OBP-401 could label malignant melanoma with GFP in situ in orthotopic mouse models. OBP-401-based fluorescence-guided surgery (FGS) resulted in the complete resection of malignant melanoma in the orthotopic models, where conventional bright-light surgery (BLS) could not. High-dose administration of OBP-401 enabled FGS without residual cancer cells or recurrence, due to its dual effect of cancer-cell labeling with GFP and killing

Precise navigation surgery of tumours in the lung in mouse models enabled by in situ fluorescence labelling with a killer-reporter adenovirus.

BackgroundCurrent methods of image-guided surgery of tumours of the lung mostly rely on CT. A sensitive procedure of selective tumour fluorescence labelling would allow simple and high-resolution visualisation of the tumour for precise surgical navigation.MethodsHuman lung cancer cell lines H460 and A549 were genetically transformed to express red fluorescent protein (RFP). Tumours were grown subcutaneously for each cell line and harvested and minced for surgical orthotopic implantation on the left lung of nude mice. Tumour growth was measured by fluorescence imaging. After the tumours reached 5 mm in diameter, they were injected under fluorescence guidance with the telomerase-dependent green fluorescent protein (GFP)-containing adenovirus, OBP-401. Viral labelling of the lung tumours with GFP precisely colocalised with tumour RFP expression. Three days after administration of OBP-401, fluorescence-guided surgery (FGS) was performed.ResultsFGS of tumours in the lung was enabled by labelling with a telomerase-dependent adenovirus containing the GFP gene. Tumours in the lung were selectively and brightly labelled. FGS enabled complete lung tumour resection with no residual fluorescent tumour.ConclusionsFGS of tumours in the lung is feasible and more effective than bright-light surgery

Tumor-targeting adenovirus OBP-401 inhibits primary and metastatic tumor growth of triple-negative breast cancer in orthotopic nude-mouse models.

Our laboratory previously developed a highly-invasive, triple-negative breast cancer (TNBC) variant using serial orthotopic implantation of the human MDA-MB-231 cell line in nude mice. The isolated variant was highly-invasive in the mammary gland and lymphatic channels and metastasized to lymph nodes in 10 of 12 mice compared to 2 of 12 of the parental cell line. In the present study, the tumor-selective telomerase dependent OBP-401 adenovirus was injected intratumorally (i.t.) (1 × 108 PFU) when the high-metastatic MDA-MB-231 primary tumor expressing red fluorescent protein (MDA-MB-231-RFP) reached approximately 500 mm3 (diameter; 10 mm). The mock-infected orthotopic primary tumor grew rapidly. After i.t. OBP-401 injection, the growth of the orthotopic tumors was arrested. Six weeks after implantation, the fluorescent area and fluorescence intensity showed no increase from the beginning of treatment. OBP-401 was then injected into high-metastatic MDA-MB-231-RFP primary orthotopic tumor growing in mice which already had developed metastasis within lymphatic ducts. All 7 of 7 control mice subsequently developed lymph node metastasis. In contrast, none of 7 mice which received OBP-401 had lymph node metastasis. Seven of 7 control mice also had gross lung metastasis. In contrast, none of the 7 mice which received OBP-401 had gross lung metastasis. Confocal laser microscopy imaging demonstrated that all control mice had diffuse lung metastases. In contrast, all 7 mice which received OBP-401 only had a few metastatic cells in the lung. OBP-401 treatment significantly extended survival of the treated mice

Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrence.

We have previously developed a genetically-engineered GFP-expressing telomerase-dependent adenovirus, OBP-401, which can selectively illuminate cancer cells. In the present report, we demonstrate that targeting a triple-negative high-invasive human breast cancer, orthotopically-growing in nude mice, with OBP-401 enables curative fluorescence-guided surgery (FGS). OBP-401 enabled complete resection and prevented local recurrence and greatly inhibited lymph-node metastasis due to the ability of the virus to selectively label and subsequently kill cancer cells. In contrast, residual breast cancer cells become more aggressive after bright (white)-light surgery (BLS). OBP-401-based FGS also improved the overall survival compared with conventional BLS. Thus, metastasis from a highly-aggressive triple-negative breast cancer can be prevented by FGS in a clinically-relevant mouse model

Processing and mechanical properties of hollow sphere aluminum foams

Hollow sphere metallic foams are a new class of cellular material that possesses the attractive advantages of uniform cell size distribution and regular cell shape. These result in more predictable physical and mechanical properties than those of cellular materials with a random cell size distribution and irregular cell shapes. In the present study, single aluminum hollow spheres with three kinds of sphere wall thickness as 0.1 mm, 0.3 mm and 0.5 mm were processed by a new pressing method. Hollow sphere aluminum foam samples were prepared by bonding together single hollow spheres with simple cubic packing (SC) and body-centered cubic packing (BCC). Compressive tests were carried out to evaluate the deformation behaviors and mechanical properties of the hollow sphere aluminum foams. Effects of the sphere wall thickness and packing style on the mechanical properties were investigated.<br /

Improved Resection and Outcome of Colon-Cancer Liver Metastasis with Fluorescence-Guided Surgery Using In Situ GFP Labeling with a Telomerase-Dependent Adenovirus in an Orthotopic Mouse Model.

Fluorescence-guided surgery (FGS) of cancer is an area of intense development. In the present report, we demonstrate that the telomerase-dependent green fluorescent protein (GFP)-containing adenovirus OBP-401 could label colon-cancer liver metastasis in situ in an orthotopic mouse model enabling successful FGS. OBP-401-GFP-labeled liver metastasis resulted in complete resection with FGS, in contrast, conventional bright-light surgery (BLS) did not result in complete resection of the metastasis. OBP-401-FGS reduced the recurrence rate and prolonged over-all survival compared with BLS. In conclusion, adenovirus OBP-401 is a powerful tool to label liver metastasis in situ with GFP which enables its complete resection, not possible with conventional BLS